Study reveals sharp surge in illicit fentanyl seizures

FHS
May 13, 2024
6:04 pm

The number of illicit fentanyl seizures by law enforcement in the United States grew by more than 1,700 percent between 2017 and 2023, according to a new analysis.

Early feasibility studies on climate-friendly albuterol inhaler completed

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler

May 11, 2024

BeiGene licenses CDK2 inhibitor from Ensem in potential $1.33B deal

BeiGene has struck a deal with Ensem Therapeutics to license an oral cyclin-dependent kinase 2 (CDK2) inhibitor in exchange for an undisclosed upfront payment and

November 22, 2023

Medics Stand Ready to Aid Groundhog Day Crowds

When 30,000 visitors swarm Gobbler’s Knob around 4 a.m. today to watch a groundhog’s fleeting appearance, about 20 health providers from five responding organizations will

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.